Outset Medical, Inc. - Common Stock, par value $0.001 per share (OM)

CUSIP: 690145107

Q1 2023 13F Holders as of 31 Mar 2023

Holder snapshot 7 signals
Share change
+3,012,370
Put/Call ratio
42%
SEC-reported price per share
$18.40
Indexed holders
159
Value change
+$47,145,083
Number of buys
90
Open additional details 1 more signal available
Number of sells
57
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
18,527,213

Security key

690145107

Report period

Q1 2023

Indexed institutions

159

Top holders

10

Ownership snapshot

Top reported holders of OM - Outset Medical, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
31 Dec 2022
13F Highest disclosed value: $118,246,717 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC has the largest disclosed position value at $118.25M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value Top 5
VANGUARD GROUP INC $118.25M
JPMORGAN CHASE & CO $116.62M
T. Rowe Price Investment Manageme... $90.88M
BlackRock Finance, Inc. $90.37M
Bellevue Group AG $73.42M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$118,246,717
4,579,656 shares
— 31 Dec 2022
JPMORGAN CHASE & CO
13F
Company
13F
—
denominator unverified
$116,616,000
4,516,461 shares
— 31 Dec 2022
T. Rowe Price Investment Management, Inc.
13F
Company
13F
—
denominator unverified
$90,884,000
3,519,870 shares
— 31 Dec 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$90,372,918
3,500,113 shares
— 31 Dec 2022
Bellevue Group AG
13F
Company
13F
—
denominator unverified
$73,423,792
2,843,679 shares
— 31 Dec 2022
Champlain Investment Partners, LLC
13F
Company
13F
—
denominator unverified
$48,035,657
1,860,405 shares
— 31 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
159
Shares
52,028,882
Indexed holders
159
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2023 vs Q4 2022 Across Filers

Q4 2022 indexed holders
147
Q1 2023 indexed holders
159
Indexed holder difference
12
Investor Q4 2022 Shares Q1 2023 Shares Share Diff Share Chg % Q4 2022 value Q1 2023 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .